Clearmind Medicine holder sells 2,102 shares

Clearmind Medicine Inc. insider HRT Financial LP reported an open-market sale of 2,102 shares of Common Stock.

Rhea-AI Filing Summary

Clearmind Medicine Inc. insider HRT Financial LP reported an open-market sale of 2,102 shares of Common Stock. The shares were sold at a price of $3.36 per share. After this transaction, HRT Financial LP directly holds 106,675 shares of Clearmind Medicine common stock.

Insights

Equity ownership analyst

HRT Financial LP made a small open-market sale and remains a sizable shareholder.

HRT Financial LP, identified as a ten percent owner of Clearmind Medicine Inc., executed an open-market sale of 2,102 common shares at $3.36 per share. This is a straightforward disposition under transaction code S.

Following the sale, HRT Financial LP directly holds 106,675 shares, indicating that most of its position remains in place according to this filing. The transaction is a routine ownership adjustment, and there is no additional context such as option exercises or derivatives in the provided data.

Insider Trade Summary

Net Seller: 2,102 shares

Net Sell 1 txn

Insider HRT FINANCIAL LP

Role 10% Owner

Sold 2,102 shs ($7K)

Type	Security	Shares	Price	Value
Sale	Common Stock	2,102	$3.36	$7K

Holdings After Transaction: Common Stock — 106,675 shares (Direct)

Key Figures

Shares sold: 2,102 shares Sale price: $3.36 per share Shares held after transaction: 106,675 shares +2 more

5 metrics

Shares sold 2,102 shares Open-market sale of Clearmind Medicine common stock

Sale price $3.36 per share Price for the 2,102 CMND shares sold

Shares held after transaction 106,675 shares Direct holdings of HRT Financial LP following the sale

Net buy/sell direction Net sell of 2,102 shares Form 4 transaction summary

Transaction code S Sale in open market or private transaction

Key Terms

open-market sale, ten percent owner, Common Stock, transaction code S

4 terms

open-market sale financial

"transaction_action: "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

ten percent owner regulatory

"is_ten_percent_owner: 1"

Common Stock financial

"security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

transaction code S regulatory

"transaction_code: "S""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did HRT Financial LP report for CMND?

HRT Financial LP reported an open-market sale of 2,102 shares of Clearmind Medicine Inc. common stock. The shares were sold at $3.36 each, as disclosed in the Form 4 insider filing.

At what price did HRT Financial LP sell Clearmind Medicine (CMND) shares?

HRT Financial LP sold its Clearmind Medicine common shares at $3.36 per share. This price applies to the 2,102 shares reported in the open-market sale on the Form 4 filing.

How many Clearmind Medicine (CMND) shares does HRT Financial LP hold after the sale?

After the reported transaction, HRT Financial LP directly holds 106,675 shares of Clearmind Medicine common stock. This post-transaction balance is disclosed in the Form 4 as total shares following the sale.

What is the transaction code used in HRT Financial LP’s CMND Form 4?

The Form 4 lists transaction code "S" for HRT Financial LP’s trade in Clearmind Medicine shares. Code S indicates a sale in an open market or private transaction, according to the filing description.

Is HRT Financial LP a major holder of Clearmind Medicine (CMND)?

HRT Financial LP is identified in the Form 4 as a ten percent owner of Clearmind Medicine Inc. This designation indicates a significant ownership stake relative to other shareholders, based on the filing’s status fields.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/16/2026 - 09:19 AM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HRT FINANCIAL LP

(Last) (First) (Middle)

3 WORLD TRADE CENTER, 175 GREENWICH STRE

76TH FLOOR

(Street)

NEW YORK NEW YORK 10007

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Clearmind Medicine Inc. [ CMND ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/12/2026		S		2,102	D	$3.36	106,675	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	Adam Nunes	06/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)